Xin-ze Liu

GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial–mesenchymal transition

Feng Niu, Liang Kong, Rui-jun Ju, 2020, Drug development and industrial pharmacy.

Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis

Liang Kong, Xue-min Yao, Fu-yi Cai, 2020, Drug development and industrial pharmacy.

Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition

Liang Kong, Rui-jun Ju, Xue-min Yao, 2020, Journal of liposome research.

RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply

Liang Kong, Rui-jun Ju, Xue-min Yao, 2019, Cancer science.

The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice.

Liang Kong, Rui-jun Ju, Si-yu He, 2021, Life sciences.

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC

Liang Kong, Rui-jun Ju, Si-yu He, 2020, International journal of nanomedicine.

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease

Liang Kong, Si-yu He, Lu Zhang, 2022, Drug delivery.

ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer's disease in APP/PS-1 mice.

Liang Kong, Lu Zhang, Xin-ze Liu, 2023, Drug development and industrial pharmacy.